No Prescription |
 |
 | ||
|
Acnecinamide Cleansing Gel Generic NIACINAMIDE |
|
| ||
No Prescription » Prescription Drugs 1 » Acnecinamide Cleansing Gel Generic NIACINAMIDE Acnecinamide Cleansing Gel helps the treatment of mild to moderate acne lesion. Cleans the skin and removes excessive sebum and oil. Acnecinamide Cleansing Gel leaves the skin feeling clean clear and refreshed without stripping or drying. Special formula helps maximize the delivery of hydrating components and nourishing vitamins (vitamin B3 provitamin B5) which help maintain the skin's essential balance.Acnecinamide Cleansing Gel cleans your skin gently with oil-free formula without causing dryness. It is ideal for all skin types. 1. Removes dirt and rinses away excess sebum without drying the skin 2. Cleans deeply and opens pores 3. Inhibits the growth of acne causing bacteria 4. Removes dead skin cells excess oils impurities and daily grime 5. Renews the skin. Direction : Clean your skin with Acnecinamide Cleansing Gel twice daily (Especially in the morning and before bed-time). Keep your skin clean to unclogged the pores. Buy Acnecinamide Cleansing Gel Generic NIACINAMIDE and other Prescription Drugs 1 products online at Medstore. 5792
About Acnecinamide Cleansing Gel Generic NIACINAMIDE: Product Type: Prescription Drugs 1 Acnecinamide Cleansing Gel (Generic NIACINAMIDE (VITAMIN B3)) Acnecinamide Cleansing Gel (Generic NIACINAMIDE) Generic NIACINAMIDE 4% 150mL Generic NIACINAMIDE Acnecinamide Cleansing Gel
View more Prescription Drugs 1 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
